GO:0036293 response to decreased oxygen levels: Cellular Hypoxia Adaptation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036293 (response to decreased oxygen levels) is the biological process by which a cell or organism changes its state or activity in response to a decline in oxygen availability.
• The best-characterized arm of this response is HIF-dependent transcriptional reprogramming, which shifts metabolism, angiogenesis, and survival programs under low oxygen.
• Oxygen sensing is not limited to HIFs; cell-cycle progression, ROS handling, and energy/sugar signaling are also remodeled during hypoxia.
• Chemical hypoxia mimetics such as cobalt chloride are widely used to trigger the response experimentally, but they are not equivalent to physiological hypoxia.
• Intermittent hyperoxia-hypoxia cycles can paradoxically amplify adaptive responses, a principle exploited in the hyperoxic-hypoxic paradox.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect which genes causally drive hypoxia adaptation and related disease phenotypes.
Description
GO:0036293, response to decreased oxygen levels, describes any process that results in a change in state or activity of a cell or an organism as a result of a stimulus reflecting a decline in oxygen. This includes changes in movement, secretion, enzyme production, and gene expression, and it is one of the most conserved stress-response programs in biology. Because oxygen is a terminal electron acceptor for oxidative phosphorylation, its decline forces rapid metabolic and transcriptional rewiring that determines whether a cell adapts, arrests, or dies. The term is therefore central to cancer biology, ischemia, inflammation, and metabolic disease research. Mechanistically, the response is dominated by hypoxia-inducible factors (HIFs), which stabilize under low oxygen and activate hundreds of target genes controlling angiogenesis, glycolysis, and survival. However, the process is broader than HIF alone: cell-cycle progression, reactive oxygen species (ROS) management, and energy/sugar signaling are also oxygen-sensitive. Experimental models range from physiological hypoxic gas breathing to chemical mimetics such as cobalt chloride, each with distinct advantages and caveats. For researchers, GO:0036293 provides a controlled vocabulary to annotate and compare hypoxia datasets across cell types and species. It also frames hypothesis-driven work: which genes are necessary for adaptation, which are sufficient to trigger it, and how these nodes can be targeted therapeutically.
response to decreased oxygen levels At A Glance
| GO ID | GO:0036293 |
|---|---|
| GO term | response to decreased oxygen levels |
| Ontology | biological_process |
| Synonym | response to lowered oxygen levels |
| Major function | Cellular and organismal adaptation to reduced oxygen availability, including transcriptional, metabolic, and cell-cycle changes |
| Key mediators | HIF transcription factors, ROS-handling enzymes, cell-cycle regulators, and energy/sugar signaling components |
| Experimental triggers | Physiological hypoxia, hypoxic gas breathing, and chemical mimetics such as cobalt chloride |
| Disease relevance | Cancer progression, metastasis, ischemia, and metabolic stress |
What Is GO:0036293?
In our own words, GO:0036293 (response to decreased oxygen levels) is the collection of cellular and organismal processes triggered when oxygen availability falls below the level a cell normally experiences. The response can include altered gene expression, metabolic shifts, changes in secretion or movement, and adjustments in enzyme production, all aimed at maintaining function or promoting survival under low oxygen. It is a biological process term, meaning it describes a program of events rather than a single molecule or location.
Why Is response to decreased oxygen levels Important in Cell Biology?
GO:0036293 matters because oxygen availability is a fundamental constraint on cell physiology, and the response to its decline influences outcomes in cancer, cardiovascular disease, and regenerative medicine. Understanding this process helps researchers interpret transcriptomic and metabolic data, design physiologically relevant experiments, and identify therapeutic targets that exploit hypoxia adaptation.
• Defines a conserved stress-response program that determines cell survival versus death under low oxygen.
• Central to tumor biology, where hypoxia drives angiogenesis, metabolic reprogramming, and metastasis.
• Relevant to ischemia-reperfusion injury and the hyperoxic-hypoxic paradox in clinical settings.
• Links oxygen sensing to cell-cycle control and proliferation arrest.
• Connects ROS biology to hypoxia adaptation and reoxygenation memory.
• Involves energy and sugar signaling pathways that coordinate metabolic supply with oxygen availability.
• Provides a framework for comparing chemical hypoxia models with physiological hypoxia.
• Supports development of imaging biomarkers for tumor hypoxia and treatment response.
• Guides CRISPR-based functional genomics of hypoxia-adaptive genes.
• Informs ozone therapy and extracorporeal oxygenation research where oxygen tension is manipulated.
What Happens During response to decreased oxygen levels?
Oxygen sensing and HIF stabilization
In simple terms: When oxygen drops, cells stabilize a master regulator called HIF that turns on survival genes.
The canonical response begins with oxygen sensing by prolyl hydroxylases, whose activity depends on molecular oxygen. When oxygen declines, HIF alpha subunits escape degradation and form active transcription factors with HIF beta, driving expression of hundreds of target genes involved in angiogenesis, glycolysis, and survival. This HIF-dependent arm is the best-characterized component of GO:0036293 and is conserved across metazoans.
Metabolic and energy signaling rewiring
In simple terms: Cells switch how they make energy and use sugars when oxygen is scarce.
Beyond HIF, hypoxia engages energy and sugar signaling pathways that adjust ATP production and carbon flux. These pathways help match metabolic supply to the reduced capacity for oxidative phosphorylation and are conserved features of the response to decreased oxygen levels. This metabolic rewiring is a core functional output of GO:0036293.
Cell-cycle and proliferation control
In simple terms: Low oxygen can slow or stop cell division to protect the cell.
Cell-cycle progression is sensitive to oxygen levels, and hypoxia can induce reversible arrest at specific checkpoints. This coupling of oxygen availability to proliferation is an important component of the response and helps prevent replication under unfavorable metabolic conditions. The mechanisms involve oxygen-dependent regulation of cell-cycle machinery.
ROS management and reoxygenation memory
In simple terms: When oxygen returns, cells remember the stress and handle reactive molecules differently.
Hypoxia and subsequent reoxygenation generate reactive oxygen species (ROS) that can damage cells. Recent work shows that hypoxia can induce a ROS-resistant memory upon reoxygenation in vivo, which promotes metastasis in part via MUC1-C. This highlights that GO:0036293 includes adaptive states that persist beyond the hypoxic period itself.
Systemic and imaging-visible responses
In simple terms: Whole tumors and tissues change their behavior in ways that can be seen with imaging.
At the tissue level, the response to decreased oxygen levels alters perfusion, metabolism, and magnetic resonance signals. Oxygen-sensitive MRI can assess tumor response to hypoxic gas breathing challenges, providing a non-invasive readout of the process. These systemic manifestations are part of the organism-level response to decreased oxygen.
Key Genes Involved in GO:0036293 response to decreased oxygen levels
The following genes and proteins are central to the response to decreased oxygen levels and are commonly studied in hypoxia research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIF1A | Master transcription factor of the hypoxic response | Core regulator of GO:0036293; knockout and knock-in models reveal HIF-dependent targets |
| EPAS1 (HIF2A) | HIF family transcription factor with distinct target specificity | Important in endothelial and tumor hypoxia responses |
| VHL | E3 ubiquitin ligase targeting HIF alpha for degradation | Loss-of-function causes constitutive HIF activation; key for hypoxia signaling studies |
| EGLN1 (PHD2) | Prolyl hydroxylase that senses oxygen and marks HIF alpha | Central oxygen sensor; knockout alters HIF stability |
| ARNT (HIF1B) | Obligate HIF heterodimer partner | Required for HIF transcriptional activity; knockout abolishes canonical hypoxia response |
| MUC1-C | Transmembrane oncoprotein linked to ROS-resistant memory | Implicated in metastasis after reoxygenation; candidate for functional studies |
| CDKN1A (p21) | Cell-cycle inhibitor | Mediates hypoxia-induced cell-cycle arrest |
| CCND1 | G1/S cell-cycle regulator | Oxygen-sensitive proliferation control |
| MKI67 | Proliferation marker | Used to assess hypoxia effects on cell division |
| SLC2A1 (GLUT1) | Glucose transporter | HIF target supporting glycolytic metabolism under hypoxia |
| LDHA | Lactate dehydrogenase A | HIF target for anaerobic glycolysis |
| VEGFA | Angiogenic growth factor | HIF target driving angiogenesis in hypoxic tissues |
| BNIP3 | BH3-only protein involved in autophagy/mitophagy | HIF target linked to hypoxia-induced autophagy |
| TXN | Thioredoxin, ROS-handling enzyme | Contributes to redox balance during hypoxia-reoxygenation |
| NFE2L2 (NRF2) | Redox-sensitive transcription factor | Cross-talks with hypoxia and ROS responses |
| HMOX1 | Heme oxygenase 1 | Stress-responsive gene induced by hypoxia and ROS |
| SLC2A3 (GLUT3) | Glucose transporter | Supports energy/sugar signaling under low oxygen |
| SNRK1 | Energy sensor kinase (plant homolog of AMPK) | Model for energy signaling during hypoxia in plants |
How Is response to decreased oxygen levels Regulated?
The response to decreased oxygen levels is regulated at multiple levels. The primary switch is oxygen-dependent hydroxylation of HIF alpha by prolyl hydroxylases, which controls HIF stability and activity. Transcriptional feedback, microRNAs, and post-translational modifications further tune the amplitude and duration of the response. Metabolic and energy sensors, including sugar-signaling pathways, integrate oxygen status with nutrient availability. ROS generated during reoxygenation can also modulate signaling and establish a memory state that influences subsequent behavior.
response to decreased oxygen levels and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HIF1A | Tumor hypoxia adaptation and angiogenesis | Knockout and point-mutation models in cancer cell lines |
| VHL | Von Hippel-Lindau disease and constitutive HIF activation | Knockout and knock-in models to study HIF stabilization |
| MUC1-C | Metastasis after reoxygenation | Overexpression and knockout models in metastasis assays |
| CDKN1A | Hypoxia-induced cell-cycle arrest | Knockout models to test proliferation control |
| EGLN1 | Oxygen sensing and HIF regulation | Point-mutation models of hydroxylase activity |
Cancer and metastasis
Hypoxia is a hallmark of solid tumors and drives aggressive phenotypes. The response to decreased oxygen levels promotes angiogenesis, metabolic reprogramming, and survival, and can induce a ROS-resistant memory upon reoxygenation that promotes metastasis in part via MUC1-C. These features make GO:0036293 a rich source of therapeutic targets and biomarkers.
Ischemia and cardiovascular disease
In ischemic tissues, the response to decreased oxygen levels determines cell survival and recovery. The hyperoxic-hypoxic paradox illustrates how controlled cycles of oxygen variation can amplify adaptive responses, with implications for conditioning strategies. Extracorporeal oxygenation and ozone therapy also manipulate oxygen tension and trigger related biology.
Metabolic and proliferative disorders
Because oxygen availability is coupled to cell-cycle progression and energy signaling, dysregulated responses can contribute to proliferative and metabolic pathologies. Studying these links helps identify nodes where oxygen sensing intersects with growth control.
From response to decreased oxygen levels-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is HIF1A required for hypoxia-induced gene expression? | HIF1A knockout cell line |
| Does a specific prolyl hydroxylase mutation alter HIF stability? | EGLN1 point-mutation knock-in |
| Can a candidate gene drive metastasis after reoxygenation? | MUC1-C overexpression and knockout in vivo models |
| How does oxygen tension affect cell-cycle progression? | CDKN1A knockout and tagged knock-in reporters |
| Which genes mediate metabolic rewiring under low oxygen? | CRISPR library screening with hypoxia selection |
| Can imaging detect tumor response to hypoxic challenge? | Oxygen-sensitive MRI in xenograft models |
How to Study the response to decreased oxygen levels Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Profiling hypoxia-induced transcriptional programs |
| CRISPR knockout screen | Genes required for hypoxia adaptation | Discovering novel regulators of GO:0036293 |
| Oxygen-sensitive MRI | Tissue oxygenation and response to hypoxic challenge | Tumor response assessment |
| ROS assays | Reactive oxygen species levels | Reoxygenation memory and oxidative stress |
| Metabolic flux analysis | Glycolysis and oxidative phosphorylation | Energy signaling under low oxygen |
| Cell-cycle analysis | Proliferation and checkpoint status | Oxygen-dependent growth control |
| Chemical hypoxia induction | HIF stabilization and downstream targets | Modeling hypoxia with cobalt chloride |
| Hyperoxic-hypoxic cycling | Adaptive response amplification | Conditioning and paradox studies |
Transcriptomic profiling
RNA-seq of cells exposed to hypoxia or chemical mimetics such as cobalt chloride reveals the gene expression program downstream of GO:0036293. Comparing physiological hypoxia with chemical induction helps distinguish HIF-dependent and HIF-independent components.
Functional genomics with CRISPR screens
CRISPR knockout and activation screens under low oxygen can identify genes that are required for or sufficient to drive adaptation. These approaches are powerful for discovering novel regulators beyond canonical HIF targets.
Imaging and metabolic assays
Oxygen-sensitive MRI and metabolic flux assays provide non-invasive and real-time readouts of the response to decreased oxygen levels. These methods are especially useful in tumor models where spatial heterogeneity matters.
Redox and reoxygenation studies
Measuring ROS and redox state during hypoxia-reoxygenation cycles reveals adaptive memory and its consequences. Such studies link GO:0036293 to oxidative stress biology and metastasis.
How CRISPR Can Be Used to Study GO:0036293 response to decreased oxygen levels
Knockout
CRISPR knockout of HIF1A, VHL, or EGLN1 provides clean genetic models to test necessity in the response to decreased oxygen levels. Knockout screens can also uncover previously unknown hypoxia-adaptive genes.
Point Mutation
Point mutations in oxygen-sensing enzymes such as EGLN1 can mimic or abolish hydroxylase activity, allowing precise dissection of oxygen-sensing thresholds. These models are valuable for linking specific residues to HIF regulation.
Knock-in
Knock-in of tagged HIF1A or reporter alleles enables real-time tracking of protein stability and localization under low oxygen. This approach helps quantify the dynamics of the response.
Overexpression
Overexpression of candidate genes such as MUC1-C can test sufficiency for phenotypes like metastasis after reoxygenation. Combined with knockout, overexpression models establish causality in GO:0036293-related biology.
How EDITGENE Supports response to decreased oxygen levels Research
Researchers studying response to decreased oxygen levels-related genes often need to determine whether a candidate gene is causally involved in adaptation, proliferation, or disease progression. EDITGENE provides publication-ready CRISPR models and screening services to answer these questions with rigor.
Contact EDITGENE today to design your custom CRISPR model for response to decreased oxygen levels research.
Frequently Asked Questions About response to decreased oxygen levels
What is GO:0036293 response to decreased oxygen levels?
GO:0036293 is a biological process term describing any change in cell or organism state or activity resulting from a decline in oxygen levels, including gene expression, metabolism, and movement changes.
What genes are involved in response to decreased oxygen levels?
Key genes include HIF1A, EPAS1, VHL, EGLN1, ARNT, and downstream targets such as VEGFA, SLC2A1, and LDHA, as well as ROS-related genes like MUC1-C.
How do cells sense decreased oxygen?
Cells sense low oxygen primarily through prolyl hydroxylases that regulate HIF alpha stability, allowing rapid transcriptional responses.
What is the role of HIF in hypoxia?
HIF transcription factors are the master regulators of the hypoxic response, activating hundreds of genes that promote survival, angiogenesis, and metabolic adaptation.
Can cobalt chloride be used to study hypoxia?
Yes, cobalt chloride is a widely used chemical hypoxia mimetic that stabilizes HIF, but it is not equivalent to physiological hypoxia and should be interpreted with care.
What is the hyperoxic-hypoxic paradox?
The hyperoxic-hypoxic paradox describes how intermittent hyperoxia followed by hypoxia can amplify adaptive responses, with applications in conditioning and therapy.
How does hypoxia affect the cell cycle?
Hypoxia can slow or arrest cell-cycle progression through oxygen-sensitive regulation of cell-cycle machinery, helping cells cope with metabolic stress.
What is hypoxia-induced ROS-resistant memory?
It is an adaptive state induced by hypoxia and reoxygenation that makes cells more resistant to ROS and can promote metastasis in part via MUC1-C.
How can I study response to decreased oxygen levels with CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes under hypoxic conditions.
What methods are used to measure hypoxia responses?
Common methods include RNA-seq, CRISPR screens, oxygen-sensitive MRI, ROS assays, and metabolic flux analysis.
Conclusion
GO:0036293 response to decreased oxygen levels is a fundamental biological process that integrates oxygen sensing, transcriptional reprogramming, metabolic adaptation, and cell-cycle control. Its relevance spans cancer, ischemia, and metabolic disease, making it a high-priority area for functional genomics. CRISPR-based models and screening approaches provide the causal evidence needed to translate hypoxia biology into therapeutic insight.
References
- 1. Lee P et al.. 2020. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.. Nat Rev Mol Cell Biol 21(5):268-283 PMID: 32144406
- 2. Muñoz-Sánchez J et al.. 2019. The use of cobalt chloride as a chemical hypoxia model.. J Appl Toxicol 39(4):556-570 PMID: 30484873
- 3. Hadanny A et al.. 2020. The Hyperoxic-Hypoxic Paradox.. Biomolecules 10(6) PMID: 32630465
- 4. Di Paolo N et al.. 2005. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy.. Redox Rep 10(3):121-30 PMID: 16156950
- 5. Ortmann B et al.. 2014. Cell cycle progression in response to oxygen levels.. Cell Mol Life Sci 71(18):3569-82 PMID: 24858415
- 6. Yang DM et al.. 2019. Oxygen-sensitive MRI assessment of tumor response to hypoxic gas breathing challenge.. NMR Biomed 32(7):e4101 PMID: 31062902
- 7. Godet I et al.. 2024. Hypoxia induces ROS-resistant memory upon reoxygenation in vivo promoting metastasis in part via MUC1-C.. Nat Commun 15(1):8416 PMID: 39341835
- 8. Cho HY et al.. 2021. Energy and sugar signaling during hypoxia.. New Phytol 229(1):57-63 PMID: 31733144
